About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On January 9, PhRMA Chief Operating Officer Lori Reilly sat down with Rebecca Willumson at Fierce JPM Week to discuss how to improve patient access and affordability. Advocating for increased oversight of middlemen – known as pharmacy benefit managers (PBMs) – and of the 340B program, Lori recommended policy solutions like ensuring PBMs share negotiated savings with patients at the pharmacy and making sure the 340B program reaches the low-income, vulnerable patients it was designed to help.
When:
January 9, 2024, at 10:45 AM PT
Speakers:
- Lori Reilly, Chief Operating Officer, PhRMA
- Rebecca Willumson, Vice President & Publisher, Fierce Life Sciences & Healthcare, Questex (Moderator)
Event
Cost and Value
Fierce JPM Week: Addressing Patient Affordability With 340B
Fierce JPM Week: Addressing Patient Affordability With 340B image